Methyl 6-bromo-1H-indazole-4-carboxylate(CAS: 885518-49-0)

Methyl 6-bromo-1H-indazole-4-carboxylate (CAS: 885518-49-0) falls under various regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. It is classified as a hazardous substance due to its bromine content and may require specific handling, storage, and disposal procedures to meet environmental and occupational safety standards.

Alternatives to Methyl 6-bromo-1H-indazole-4-carboxylate in synthesis might include other brominated indazoles or related heterocycles. Common substitutes could involve using 6-chloro-1H-indazole-4-carboxylic acid or 6-fluoro-1H-indazole-4-carboxylic acid, depending on the specific synthetic pathway and desired properties of the final product.

The market for Methyl 6-bromo-1H-indazole-4-carboxylate (CAS: 885518-49-0) is primarily driven by its use in drug discovery and synthesis for medicinal chemistry. Research trends indicate a growing interest in indazoles for their potential in developing anti-inflammatory, anti-tumor, and other therapeutic agents. Market dynamics show increasing demand, particularly from pharmaceutical companies looking to explore novel chemical entities.

Waste containing Methyl 6-bromo-1H-indazole-4-carboxylate (CAS: 885518-49-0) should be collected in appropriate containers and stored in a secure location. Proper incineration or professional waste disposal services should be utilized to ensure safe disposal. Environmental precautions include ensuring no release into the environment, and all handling should comply with local and international regulations to prevent contamination and protect public health and the environment.